Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Lyndal K. Hesterberg"'
Autor:
Michael Centola, Guy Cavet, Yijing Shen, Saroja Ramanujan, Nicholas Knowlton, Kathryn A Swan, Mary Turner, Chris Sutton, Dustin R Smith, Douglas J Haney, David Chernoff, Lyndal K Hesterberg, John P Carulli, Peter C Taylor, Nancy A Shadick, Michael E Weinblatt, Jeffrey R Curtis
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e60635 (2013)
BACKGROUND: Disease activity measurement is a key component of rheumatoid arthritis (RA) management. Biomarkers that capture the complex and heterogeneous biology of RA have the potential to complement clinical disease activity assessment. OBJECTIVES
Externí odkaz:
https://doaj.org/article/ba6bf4f96cb349b5bf3986154ec85038
Publikováno v:
Allosteric Enzymes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f955505c50ac2b7e8c182e9bd2531e1
https://doi.org/10.1201/9781003068563-10
https://doi.org/10.1201/9781003068563-10
Autor:
Rea A. Cuaresma, Robert Langer, Xiaoyan Zhao, Lyndal K. Hesterberg, Daniel Hornburg, Asim Siddiqui, Hongwei Xia, Philip Ma, Steven A. Carr, Omid C. Farokhzad, Behzad Tangeysh, Shadi Ferdosi, Hope Liou, William C. Manning, John E. Blume, Greg Troiano, Max Mahoney, Stolarczyk Craig, Michael Figa, Patrick A. Everley, Eltaher M. Elgierari, Theodore L. Platt, Ryan W. Benz, Marwin Ko, Vivek F. Farias
Publikováno v:
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
Large-scale, unbiased proteomics studies are constrained by the complexity of the plasma proteome. Here we report a highly parallel protein quantitation platform integrating nanoparticle (NP) protein coronas with liquid chromatography-mass spectromet
Autor:
Marije F. Bakker, Michael Centola, Floris P J G Lafeber, Johannes W G Jacobs, Dustin Smith, Yijing Shen, Joel A G van Roon, Johannes W. J. Bijlsma, Lyndal K. Hesterberg, Douglas J. Haney, Paco M J Welsing, Guy Cavet
Publikováno v:
Annals of the Rheumatic Diseases
Objectives To evaluate the performance of individual biomarkers and a multi-biomarker disease activity (MBDA) score in the early rheumatoid arthritis (RA) patient population from the computer assisted management in early rheumatoid arthritis (CAMERA)
Autor:
Xiaoyan Zhao, William H. Robinson, Ferhan Qureshi, William C. Manning, P. Scott Eastman, Claire Alexander, Lyndal K. Hesterberg
Publikováno v:
Journal of Immunological Methods. 378(1-2):72-80
Variability in pre-analytical blood sampling and handling can significantly impact results obtained in quantitative immunoassays. Understanding the impact of these variables is critical for accurate quantification and validation of biomarker measurem
Publikováno v:
Current Pharmaceutical Biotechnology. 10:447-455
Non-denaturing pressures of around 2000 bar are effective for eliminating and refolding protein aggregates and may be applicable in various phases of protein manufacturing to decrease aggregate levels in products and improve process yields. Lower agg
Autor:
David J Phelps, Lyndal K Hesterberg
Publikováno v:
Journal of Chemical Technology & Biotechnology. 82:610-613
Production of recombinant proteins often leads to aggregate formation. These aggregates may make it impossible to solubilize the protein for downstream applications such as assay development or structural studies by X-ray crystallography or nuclear m
Autor:
Mark Crosby, Lyndal K. Hesterberg
Publikováno v:
Laboratory Medicine. 27:41-46
The managed care environment dictates that patients be diagnosed quickly and efficiently. In many cases, the use of point-of-care (POC) immunoassays helps meet this requirement. Rapid immunoassays performed at the point of care allow test results to
Autor:
Yijing Shen, Nancy A. Shadick, Lyndal K. Hesterberg, David Chernoff, Douglas J. Haney, Roy Fleischmann, Rachel Knevel, Edward C. Keystone, Annette H M van der Helm-van Mil, Michael Centola, Kerri Ford, Jeffrey R. Curtis, Max Hamburger, Guy Cavet, Saroja Ramanujan, Michael E. Weinblatt, Tom W J Huizinga
Publikováno v:
Arthritis Care & Research
Objective Quantitative assessment of disease activity in rheumatoid arthritis (RA) is important for patient management, and additional objective information may aid rheumatologists in clinical decision making. We validated a recently developed multib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c3d8fe9aef77f1784f0e4a95b1323a6
http://hdl.handle.net/1887/96695
http://hdl.handle.net/1887/96695
Autor:
Michael E. Weinblatt, Dustin Smith, David Chernoff, Yijing Shen, Nicholas Knowlton, John P. Carulli, Lyndal K. Hesterberg, Nancy A. Shadick, Kathryn A. Swan, Saroja Ramanujan, Guy Cavet, Douglas J. Haney, Christopher Sutton, Michael Centola, Jeffrey R. Curtis, Peter C. Taylor, Mary Turner
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 4, p e60635 (2013)
PLoS ONE, Vol 8, Iss 4, p e60635 (2013)
Background Disease activity measurement is a key component of rheumatoid arthritis (RA) management. Biomarkers that capture the complex and heterogeneous biology of RA have the potential to complement clinical disease activity assessment. Objectives